Navy Continues COVID-19 Vaccine Separations as Fourth Vaccine Eyes Conditional FDA Approval

[Tony]

Some sailors have received a COVID-19 vaccine that is developed differently from existing vaccines and could overcome religious objections that have been fought over in federal court.

A small percentage of sailors received Novavax COVID-19 while overseas, where the shot is considered approved, said Ed Gulick, a spokesperson for Navy medicine.

Novavax is seeking emergency use authorization from the FDAA for its version of a COVID-19 vaccine. However, that approval could be delayed, according to Axios. Novavax developed a protein-based vaccine, which is a common method for vaccines, against COVID-19. Some have theorized that those uncomfortable with the mRNA vaccines from Pfizer and Moderna due to their reliance on a certain line of fetal cells and idea that the mRNA changes their bodies may be more willing to get the Novavax option, according to science journal Nature.